Six new cerebrosides (ceramide monohexosides), acanthacerebroside A (1), B (2), C (3), D (4), E (5), and F (6) were isolated from the water‐insoluble lipid fraction of the chloroform‐methanol extract of the starfish Acanthaster planci. On the basis of chemical and spectral evidences, they were characterized as 1‐O‐(β‐D‐glucopyranosyl)‐substituted (1S,3S,4R)‐2‐[(2R)‐2‐hydroxytetracosanoylamino]‐1,3,4‐hexadecanetriol (1), (2S,3S,4R)‐2‐[(2R)‐2‐hydroxyhexadecanoylamino]‐1,3,4‐docosanetriol (2), (2S,3S,4R,13E)‐2‐[(2R)‐2‐hydroxyhexadecanoylamino]‐13‐docosene‐1,3,4‐triol (3), (2S,3R,4E,10E)‐2‐[(2R)‐2‐hydroxydocosanoylamino]‐4,10‐octadecadiene‐1,3‐diol (4), (2S,3R,4E,10E)‐2‐[(2R)‐2‐hydroxydocosanoylamino]‐4,10‐octadecadiene‐1,3‐diol (5), and (2S,3R,4E,10E)‐2‐[(2R)‐2‐hydroxytetracosanoylamino]‐4,10‐octadecadiene‐1,3‐diol (6). Reversed‐phase HPLC was effective to isolate these cerebrosides revealing the very close resemblance in structure. Negative FABMS spectrometry was useful in providing information on the molecular mass of the cerebrosides.
No takes yet. Share an insight, caveat, or question.
Kawano et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: